What’s Driving the Rise of Consumer Diagnostics?
At MedCity INVEST Digital Health, experts from Jona, Labcorp and Evvy discussed the drivers of consumer diagnostics.
Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M
Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction
Labcorp’s $239 million offer was selected as the winning bid for the assets of genetic testing company Invitae, which filed for bankruptcy protection earlier this year. The acquisition deal, Labcorp's second in the past month, will enable it to expand in oncology and rare diseases.
Labcorp’s $237M Tuck-In Deal Brings Lab Testing Assets From BioReference Health
Labcorp is buying the clinical diagnostics and reproductive women’s health businesses of BioReference Health, excluding those assets in New York and New Jersey. Labcorp has returned to being fully focused on lab testing after last year’s spinoff of Fortrea, its former clinical trial services business.
Labcorp Shells Out $146M to Buy Enzo Biochem’s Clinical Lab Business
Enzo BioChem’s sale of its clinical lab business to Labcorp is the culmination of a monthslong strategic review. Meanwhile, diagnostics and lab testing giant Labcorp is in the middle of its own corporate shakeup as it readies its clinical trials business for a spinoff as a standalone, publicly traded company.
LabCorp plans to break out its $6B drug development biz as a standalone company
Laboratory testing and clinical trial services giant LabCorp plans to spin off its drug development business as an independent, publicly traded company. It’s the latest in a string of corporate moves for the life sciences sector as companies look to streamline operations in order to focus on particular areas of growth.
How Innovation in BTK Inhibitor Development Is Improving Treatment Outcomes
BTK inhibitor has become an important treatment option for certain B-cell malignancies.
FDA authorizes Labcorp’s at-home test kit for Covid-19, flu
The Food and Drug Administration granted an emergency use authorization for an at-home Covid-19 and flu test kit by Labcorp. It uses a test that was developed by Roche and authorized last year.
Labcorp buys fertility benefits company Ovia
The company purchased digital health company Ovia Health for an undisclosed amount. It makes apps for fertility tracking, pregnancy stages and parenting advice.
CMS to pay less for Covid-19 test results that take longer than two days
Starting in January, Medicare will pay $75 for tests that take longer than two days to deliver results. It currently pays $100 for each high-throughput Covid-19 test.
How Covid-19 is accelerating adoption of decentralized clinical trials
Late last month, Medable and LabCorp CRO Covance signed a deal to accelerate adoption of decentralized trials, a trend that has been helped along as Covid-19 has created challenges to conducting trials dependent on traditional brick-and-mortar sites.
presented by
From Blind Spots to Better Outcomes: How SNF Data Transparency Strengthens LTSS
What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes.
LabCorp first to get FDA green light for Covid-19 at-home testing kit
The agency reissued the emergency use authorization that it gave to LabCorp last month for its RT-PCR test to allow for collection of samples at home by patients, with a doctor's order.
RDMD raises $14M for rare disease real-world evidence generation
The San Francisco-based startup is one of several that have been raising money over the past couple of weeks in areas like neurology, oncology and women's health.
FDA grants Hologic, LabCorp Covid-19 diagnostic EUAs, gives states greater leeway for testing
The EUAs follow the ones the agency gave last week to Roche and Thermo Fisher Scientific. The agency is also allowing states to take greater responsibility for authorizing tests for the SARS-CoV-2 virus.
How have these firms making Covid-19 news fared as stock markets have tanked?
While all these companies have been involved in developing testing, vaccines and drugs for SARS-CoV-2, fears related to the global coronavirus pandemic have taken their toll on them as well as firms in other sectors.
AMCA data breach potentially hits an additional 7.7M LabCorp customers
AMCA has told LabCorp that it is in the process of sending notices to the approximately 200,000 of the company's consumers whose credit card or bank account information may have been accessed and will offer them identity protection and credit monitoring services for 24 months.